David Earl Bogucki

City:

Surrey

Country:

Canada

Published Applications:

Last publication date:

2024-09-05

Top Assignees for applications by David Earl Bogucki

The entities that hold a legal rights for patent applications filed by inventor Bogucki David Earl:

Genzyme Corporation 3 Cambridge, MA United States
XENON PHARMACEUTICALS INC. 1 Burnaby, Canada
APOGEE PHARMACEUTICALS, INC. 1 Burnaby, Canada
AnorMED Inc. 1 Langley, Canada

Recent patent applications by Bogucki David Earl

David Earl Bogucki from Surrey, CA has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-09-05

US20240294514A1

Chemistry; metallurgy

SMALL MOLECULES AS MONOACYLGLYCEROL LIPASE (MAGL) INHIBITORS, COMPOSITIONS AND USE THEREOF

#2 | 2021-06-10

US20210171537A1

Chemistry; metallurgy

Benzenesulfonamide compouds and their use as therapeutic agents

#3 | 2018-06-14

US20180162868A1

Chemistry; metallurgy

BENZENESULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS

#4 | 2016-08-11

US20160228413A1

Human necessities

Chemokine receptor binding heterocyclic compounds with enhanced efficacy

#5 | 2015-02-05

US20150038509A1

Chemistry; metallurgy

Chemokine Receptor Binding Heterocyclic Compounds With Enhanced Efficacy

#6 | 2008-11-20

US20080287454A1

Chemistry; metallurgy

CXCR4 antagonists

#7 | 2007-03-15

US20070060591A1

Chemistry; metallurgy

Chemokine receptor binding heterocyclic compounds

#8 | 2006-04-04

US10703781

Chemokine receptor binding heterocyclic compounds

#9 | 2006-03-30

US20060069129A1

Chemistry; metallurgy

Chemokine receptor binding heterocyclic compounds

#10 | 2005-07-14

US20050154005A1

Chemistry; metallurgy

Methods to modulate conditions mediated by the CXCR4 receptor

InventorID:

1059565 ⎘